Filed: 2/13/2026ACC: 0000905148-26-000704
📋 What this filing means
DAVERN CAPITAL PARTNERS, LP filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $309.30M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$309.30M
Total AUM (reported)
6.44M
Total Shares
Allocation by class
COM$159.64M51.6%
SPONSORED ADS$64.85M21.0%
SHS CLASS A$32.48M10.5%
SPONSORED ADR$30.01M9.7%
SHS$22.31M7.2%
Portfolio Concentration
Top 3$126.65M40.9%
4–10$153.59M49.7%
11–25$29.05M9.4%
Top 3 weight
40.9%
Top 10 weight
90.6%
Voting Authority Distribution
Total shares with voting rights: 6.44M
Sole
Full voting authority
484.57K
shares
% of voting shares7.5%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
5.95M
shares
% of voting shares92.5%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeNone · 92.5% of voting shares
Institutional Holdings14
Rows:
PFIZER INC
SOLEShares2.04M
TypeSH
Market value$50.85M
16.44%
Sole
154.83K
Shared
0.00
None
1.89M
REGENERON PHARMACEUTICALS
SOLEShares52.42K
TypeSH
Market value$40.46M
13.08%
Sole
3.99K
Shared
0.00
None
48.43K
BIONTECH SE
SOLEShares371.22K
TypeSH
Market value$35.34M
11.43%
Sole
27.45K
Shared
0.00
None
343.76K
ROYALTY PHARMA PLC
SOLEShares840.65K
TypeSH
Market value$32.48M
10.50%
Sole
63.88K
Shared
0.00
None
776.77K
ARGENX SE
SOLEShares35.69K
TypeSH
Market value$30.01M
9.70%
Sole
2.70K
Shared
0.00
None
32.98K
LEGEND BIOTECH CORP
SOLEShares1.06M
TypeSH
Market value$22.97M
7.43%
Sole
78.96K
Shared
0.00
None
977.71K
ROIVANT SCIENCES LTD
SOLEShares1.03M
TypeSH
Market value$22.31M
7.21%
Sole
78.18K
Shared
0.00
None
950.12K
IONIS PHARMACEUTICALS INC
SOLEShares238.48K
TypeSH
Market value$18.87M
6.10%
Sole
17.55K
Shared
0.00
None
220.93K
NATERA INC
SOLEShares78.65K
TypeSH
Market value$18.02M
5.83%
Sole
5.79K
Shared
0.00
None
72.86K
ELI LILLY & CO
SOLEShares8.31K
TypeSH
Market value$8.93M
2.89%
Sole
612.00
Shared
0.00
None
7.70K
VIRIDIAN THERAPEUTICS INC
SOLEShares261.62K
TypeSH
Market value$8.14M
2.63%
Sole
19.26K
Shared
0.00
None
242.36K
MINERALYS THERAPEUTICS INC
SOLEShares210.65K
TypeSH
Market value$7.64M
2.47%
Sole
15.51K
Shared
0.00
None
195.14K
CG ONCOLOGY INC
SOLEShares162K
TypeSH
Market value$6.73M
2.17%
Sole
12.27K
Shared
0.00
None
149.73K
ABIVAX SA
SOLEShares48.50K
TypeSH
Market value$6.54M
2.11%
Sole
3.59K
Shared
0.00
None
44.91K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PFIZER INCSOLE | COM | 2.04M | SH | $50.85M 16.44% | 154.83K | 0.00 | 1.89M |
REGENERON PHARMACEUTICALSSOLE | COM | 52.42K | SH | $40.46M 13.08% | 3.99K | 0.00 | 48.43K |
BIONTECH SESOLE | SPONSORED ADS | 371.22K | SH | $35.34M 11.43% | 27.45K | 0.00 | 343.76K |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 840.65K | SH | $32.48M 10.50% | 63.88K | 0.00 | 776.77K |
ARGENX SESOLE | SPONSORED ADR | 35.69K | SH | $30.01M 9.70% | 2.70K | 0.00 | 32.98K |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 1.06M | SH | $22.97M 7.43% | 78.96K | 0.00 | 977.71K |
ROIVANT SCIENCES LTDSOLE | SHS | 1.03M | SH | $22.31M 7.21% | 78.18K | 0.00 | 950.12K |
IONIS PHARMACEUTICALS INCSOLE | COM | 238.48K | SH | $18.87M 6.10% | 17.55K | 0.00 | 220.93K |
NATERA INCSOLE | COM | 78.65K | SH | $18.02M 5.83% | 5.79K | 0.00 | 72.86K |
ELI LILLY & COSOLE | COM | 8.31K | SH | $8.93M 2.89% | 612.00 | 0.00 | 7.70K |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 261.62K | SH | $8.14M 2.63% | 19.26K | 0.00 | 242.36K |
MINERALYS THERAPEUTICS INCSOLE | COM | 210.65K | SH | $7.64M 2.47% | 15.51K | 0.00 | 195.14K |
CG ONCOLOGY INCSOLE | COM | 162K | SH | $6.73M 2.17% | 12.27K | 0.00 | 149.73K |
ABIVAX SASOLE | SPONSORED ADS | 48.50K | SH | $6.54M 2.11% | 3.59K | 0.00 | 44.91K |